These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation. Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity. Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580 [TBL] [Abstract][Full Text] [Related]
6. Positive virtual crossmatch with negative flow crossmatch results in two cases. Jacob EK; De Goey SR; Gandhi MJ Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997 [TBL] [Abstract][Full Text] [Related]
7. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059 [TBL] [Abstract][Full Text] [Related]
8. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation. Kobayashi T; Maruya E; Niwa M; Saji H; Kohara S; Katayama A; Takeda A; Watarai Y; Uchida K Hum Immunol; 2011 Jan; 72(1):11-7. PubMed ID: 20974206 [TBL] [Abstract][Full Text] [Related]
9. Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection. Hwang HS; Sun IO; Yoon HE; Choi BS; Oh EJ; Kim JI; Moon IS; Kim YS; Yang CW Hum Immunol; 2012 Apr; 73(4):370-5. PubMed ID: 22342452 [TBL] [Abstract][Full Text] [Related]
10. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726 [TBL] [Abstract][Full Text] [Related]
11. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay. Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398 [TBL] [Abstract][Full Text] [Related]
12. Luminex donor-specific crossmatches. Billen EV; Voorter CE; Christiaans MH; van den Berg-Loonen EM Tissue Antigens; 2008 Jun; 71(6):507-13. PubMed ID: 18380779 [TBL] [Abstract][Full Text] [Related]
13. Comparative performance evaluation of a donor-specific bead-based crossmatch technique for the detection of donor-specific anti-HLA antibodies in heart transplantation. Chaidaroglou A; Skoura A; Degiannis D Transplant Proc; 2013 Jun; 45(5):2005-8. PubMed ID: 23769095 [TBL] [Abstract][Full Text] [Related]
14. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens. Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of two methods to detect donor-specific anti-HLA antibodies after kidney transplant. Gil BC; Kulzer ASS; de Moraes P; Toresan R; da Rosa Vicari A; Dos Santos Fagundes I; Merzoni J; Ewald GM; Cardone JM; Silva FG; Manfro RC; Jobim LF Transpl Immunol; 2018 Aug; 49():7-11. PubMed ID: 29577967 [TBL] [Abstract][Full Text] [Related]
17. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Aubert V; Venetz JP; Pantaleo G; Pascual M Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474 [TBL] [Abstract][Full Text] [Related]
18. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants. Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates. Arnold ML; Dechant M; Doxiadis II; Spriewald BM Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575 [TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]